| Recent advancements in liposome technology N Filipczak, J Pan, SSK Yalamarty, VP Torchilin Advanced drug delivery reviews 156, 4-22, 2020 | 355 | 2020 |
| Recent advances in tumor targeting via EPR effect for cancer treatment MA Subhan, SSK Yalamarty, N Filipczak, F Parveen, VP Torchilin Journal of personalized medicine 11 (6), 571, 2021 | 241 | 2021 |
| Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin MM Khan, A Madni, V Torchilin, N Filipczak, J Pan, N Tahir, H Shah Drug delivery 26 (1), 765-772, 2019 | 114 | 2019 |
| Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer MM Khan, N Filipczak, VP Torchilin Journal of controlled release 330, 1220-1228, 2021 | 96 | 2021 |
| Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance J Pan, LP Mendes, M Yao, N Filipczak, S Garai, GA Thakur, C Sarisozen, ... European Journal of Pharmaceutics and Biopharmaceutics 136, 18-28, 2019 | 95 | 2019 |
| Long-circulating curcumin-loaded liposome formulations with high incorporation efficiency, stability and anticancer activity towards pancreatic adenocarcinoma cell lines in vitro M Mahmud, A Piwoni, N Filiczak, M Janicka, J Gubernator PloS one 11 (12), e0167787, 2016 | 87 | 2016 |
| Polymeric co-delivery systems in cancer treatment: an overview on component drugs’ dosage ratio effect J Pan, K Rostamizadeh, N Filipczak, VP Torchilin Molecules 24 (6), 1035, 2019 | 80 | 2019 |
| Synthesis and antioxidant activity of caffeic acid derivatives K Sidoryk, A Jaromin, N Filipczak, P Cmoch, M Cybulski Molecules 23 (9), 2199, 2018 | 65 | 2018 |
| Nano silver-induced toxicity and associated mechanisms J Zhang, F Wang, SSK Yalamarty, N Filipczak, Y Jin, X Li International journal of nanomedicine, 1851-1864, 2022 | 48 | 2022 |
| Hypoxia-sensitive micellar nanoparticles for co-delivery of siRNA and chemotherapeutics to overcome multi-drug resistance in tumor cells U Joshi, N Filipczak, MM Khan, SA Attia, V Torchilin International Journal of Pharmaceutics 590, 119915, 2020 | 47 | 2020 |
| Anacardic acid enhances the anticancer activity of liposomal mitoxantrone towards melanoma cell lines–in vitro studies M Legut, D Lipka, N Filipczak, A Piwoni, A Kozubek, J Gubernator International journal of nanomedicine, 653-668, 2014 | 46 | 2014 |
| Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy MM Khan, A Madni, N Filipczak, J Pan, M Rehman, N Rai, SA Attia, ... Nanomedicine: Nanotechnology, Biology and Medicine 28, 102228, 2020 | 40 | 2020 |
| Vitamin C-driven epirubicin loading into liposomes D Lipka, J Gubernator, N Filipczak, S Barnert, R Süss, M Legut, ... International journal of nanomedicine, 3573-3585, 2013 | 35 | 2013 |
| Monoclonal antibody 2C5-modified mixed dendrimer micelles for tumor-targeted codelivery of chemotherapeutics and siRNA J Pan, SA Attia, MA Subhan, N Filipczak, LP Mendes, X Li, ... Molecular Pharmaceutics 17 (5), 1638-1647, 2020 | 29 | 2020 |
| Developments in treatment methodologies using dendrimers for infectious diseases N Filipczak, SSK Yalamarty, X Li, F Parveen, V Torchilin Molecules 26 (11), 3304, 2021 | 26 | 2021 |
| A triple co-delivery liposomal carrier that enhances apoptosis via an intrinsic pathway in melanoma cells N Filipczak, A Jaromin, A Piwoni, M Mahmud, C Sarisozen, V Torchilin, ... Cancers 11 (12), 1982, 2019 | 26 | 2019 |
| Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM) SSK Yalamarty, N Filipczak, X Li, MA Subhan, F Parveen, JA Ataide, ... Cancers 15 (7), 2116, 2023 | 25 | 2023 |
| Lipid-based drug delivery systems in regenerative medicine N Filipczak, SSK Yalamarty, X Li, MM Khan, F Parveen, V Torchilin Materials 14 (18), 5371, 2021 | 20 | 2021 |
| The cytotoxic action of cytochrome C/Cardiolipin nanocomplex (Cyt-CL) on cancer cells in culture YA Vladimirov, C Sarisozen, GK Vladimirov, N Filipczak, AM Polimova, ... Pharmaceutical research 34, 1264-1275, 2017 | 20 | 2017 |
| Co-delivery of siRNA and chemotherapeutic drug using 2C5 antibody-targeted dendrimer-based mixed micelles for multidrug resistant cancers SSK Yalamarty, N Filipczak, X Li, TV Pathrikar, C Cotter, VP Torchilin Pharmaceutics 14 (7), 1470, 2022 | 14 | 2022 |
